Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

被引：28
|
作者：
Chalhoub, Hussein [1 ]
Tunney, Michael [2 ]
Elborn, J. Stuart [2 ]
Vergison, Anne [3 ]
Denis, Olivier [4 ]
Plesiat, Patrick [5 ]
Kahl, Barbara C. [6 ]
Van Bambeke, Francoise [1 ]
Tulkens, Paul M. [1 ]
机构：
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium
[2] Queens Univ Belfast, CF & Airways Microbiol Res Grp, Belfast, Antrim, North Ireland
[3] Hop Univ Enfants Reine Fabiola, Unite Malad Infect, Brussels, Belgium
[4] Free Univ Brussels, Hop Erasme, Lab Microbiol, B-1070 Brussels, Belgium
[5] Hop Jean Minjoz, Lab Bacteriol, F-25030 Besancon, France
[6] Univ Hosp Munster, Med Microbiol, Munster, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2015年 / 70卷 / 05期
关键词：
carbapenemases; extended-spectrum beta-lactamases; ESBLs; beta-lactamase inhibition; P; aeruginosa; IN-VITRO ACTIVITY; EXACERBATIONS;
D O I：
10.1093/jac/dku551
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1596 / 1598
页数：4
相关论文
共 50 条
  • [1] In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
    Kresken, Michael
    Korte-Berwanger, Miriam
    Pfennigwerth, Niels
    Gatermann, Soren G.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 337 - 338
  • [2] Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactam
    Atkin, Stan D.
    Abid, Shadaan
    Foster, Michael
    Bose, Moumita
    Keller, Ashley
    Hollaway, Rita
    Sader, Helio S.
    Greenberg, David E.
    Finklea, James D.
    Castanheira, Mariana
    Jain, Raksha
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 1499 - 1510
  • [3] Evaluation of the In vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Ceftazidime-Resistant Pseudomonas aeruginosa Isolates
    Bilgin, Melek
    Basbulut, Ese
    Isler, Hacer
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (04): : 713 - 719
  • [4] Susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients to ciprofloxacin
    Bauernfeind, A
    Jungwirth, R
    Ratjen, F
    DRUGS, 1999, 58 (Suppl 2) : 209 - 210
  • [5] Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients to Ciprofloxacin
    A. Bauernfeind
    R. Jungwirth
    F. Ratjen
    Drugs, 1999, 58 : 209 - 210
  • [6] Susceptibility of Pseudomonas aeruginosa to cefepime versus ceftazidime in patients with cystic fibrosis
    Robinson, CA
    Kuhn, RJ
    Craigmyle, LJ
    Anstead, MI
    Kanga, JF
    PHARMACOTHERAPY, 2001, 21 (11): : 1320 - 1324
  • [7] In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Manduru, M
    Mihm, LB
    White, RL
    Friedrich, LV
    Flume, PA
    Bosso, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2053 - 2056
  • [8] Molecular Epidemiology of Beta-Lactamases in Ceftazidime-Resistant Pseudomonas aeruginosa Isolates
    Er, Halil
    Altindis, Mustafa
    Asik, Gulsah
    Demir, Cengiz
    MIKROBIYOLOJI BULTENI, 2015, 49 (02): : 156 - 165
  • [9] Population Structure and Antimicrobial Susceptibility of Both Nonpersistent and Persistent Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Patients
    Fernandez-Olmos, Ana
    Garcia-Castillo, Mara
    Maria Alba, Jose
    Isabel Morosini, Mara
    Lamas, Adelaida
    Romero, Beatriz
    Carlos Galan, Juan
    del Campo, Rosa
    Canton, Rafael
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (08) : 2761 - 2765
  • [10] EVALUATION OF BIOFILM PRODUCTION BY PSEUDOMONAS AERUGINOSA ISOLATES RECOVERED FROM CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS PATIENTS
    Perez, L. R. R.
    Costa, M. C. N.
    Freitas, A. L. P.
    Barth, A. L.
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2011, 42 (02) : 476 - 479
12345